What they were paid
MoonLake Immunotherapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $75,000 | $0 | $224,349 | $0 | $299,349 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: MoonLake Immunotherapeutics DEF 14A filed April 21, 2026, accession 0001140361-26-015916, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025MoonLake Immunotherapeutics pays directors a $40,000 cash retainer and $224,349 in equity.
The rest of the MoonLake Immunotherapeutics board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Catherine Moukheibir | Independent Director | $286,849 |
| Dr. Andrew Phillips | Independent Director | $280,349 |
| Dr. Jorge Santos da Silva | Chair of the Board | $0 |
| Spike Loy | Lead Independent Director | $276,849 |
The full MoonLake Immunotherapeutics compensation record
free company briefThis page is one director within MoonLake Immunotherapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat